RVPH - Financial Reports List - Reviva Pharmaceuticals Holdings, Inc. - IntrinsicAlpha

Reviva Pharmaceuticals Holdings, Inc. RVPH

Healthcare - Biotechnology - NASDAQ - US

$ 1.05

-4.81 %

$ 49.1 M

Market Cap

-1.27

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	35.63%	37.08%
Annual Report	FY	10-K	2024-12-31	0.00%	23.79%	22.04%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	20.26%	20.98%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	36.83%	32.65%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-12.59%	-17.62%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-19.78%	-28.49%
Annual Report	FY	10-K	2023-12-31	0.00%	-61.31%	-62.52%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-198.44%	-200.57%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-132.98%	-118.69%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	10.35%	9.59%

1